
Telix Pharmaceuticals fell 2.6% from $9.16 to $8.92, behind the S&P 500's +11.2%. Its worst day was Sep 21 (−10.2%), and its low came Feb 18 at $6.41.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Telix Pharmaceuticals shares rose 9.3%, while the S&P 500 rose 0.4%.
+9.3% · S&P 500 +0.4%
Telix Pharmaceuticals closed at its lowest level of the year, 30.0% below where the year started.
−0.2% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
Telix Pharmaceuticals shares rose 10.8%, while the S&P 500 fell 0.6%.
+10.8% · S&P 500 −0.6%
Telix Pharmaceuticals closed at its highest level of the year, 40.1% above where the year started.
+8.9%, on 1M shares, the year's heaviest volume · S&P 500 −0.5%
Telix Pharmaceuticals shares fell 10.1%, while the S&P 500 rose 0.5%.
−10.1% · S&P 500 +0.5%
Where it ended: a close of $8.92 on Nov 16, 2026.
Nothing in the past 12 months.
All TLX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TLX and SPY from Benzinga historical bars. Not investment advice.